These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 11777293)
1. 8. The dilemma of in situ carcinoma of the breast. Fentiman IS Int J Clin Pract; 2001 Dec; 55(10):680-3. PubMed ID: 11777293 [TBL] [Abstract][Full Text] [Related]
2. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Li CI; Malone KE; Saltzman BS; Daling JR Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564 [TBL] [Abstract][Full Text] [Related]
3. Is there a low-grade precursor pathway in breast cancer? King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747 [TBL] [Abstract][Full Text] [Related]
4. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy. Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852 [TBL] [Abstract][Full Text] [Related]
5. Epidemiological survey of preinvasive breast cancer. Vandenbroucke A; Bourdon C Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():3-10. PubMed ID: 8298449 [TBL] [Abstract][Full Text] [Related]
6. [In situ carcinomas of the breast: clinical features and therapeutic strategies]. Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353 [TBL] [Abstract][Full Text] [Related]
7. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ. Fisher ER; Costantino J; Fisher B; Palekar AS; Paik SM; Suarez CM; Wolmark N Cancer; 1996 Oct; 78(7):1403-16. PubMed ID: 8839545 [TBL] [Abstract][Full Text] [Related]
8. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience. Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223 [TBL] [Abstract][Full Text] [Related]
9. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
10. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Fisher ER; Land SR; Fisher B; Mamounas E; Gilarski L; Wolmark N Cancer; 2004 Jan; 100(2):238-44. PubMed ID: 14716756 [TBL] [Abstract][Full Text] [Related]
11. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma? Bagaria SP; Shamonki J; Kinnaird M; Ray PS; Giuliano AE Ann Surg Oncol; 2011 Jul; 18(7):1845-51. PubMed ID: 21287281 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. Vo TN; Meric-Bernstam F; Yi M; Buchholz TA; Ames FC; Kuerer HM; Bedrosian I; Hunt KK Am J Surg; 2006 Oct; 192(4):552-5. PubMed ID: 16978974 [TBL] [Abstract][Full Text] [Related]
13. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy. Jolly S; Kestin LL; Goldstein NS; Vicini FA Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988 [TBL] [Abstract][Full Text] [Related]
14. [Carcinoma in situ of the breast]. Laenkholm AV; Hoffmann J; Rank FE Ugeskr Laeger; 2007 Sep; 169(37):3087-90. PubMed ID: 17877955 [TBL] [Abstract][Full Text] [Related]
15. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Renshaw AA; Cartagena N; Derhagopian RP; Gould EW Am J Clin Pathol; 2002 May; 117(5):797-9. PubMed ID: 12090431 [TBL] [Abstract][Full Text] [Related]
16. Optimal management of ductal carcinoma in situ of the breast. Sakorafas GH; Farley DR Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563 [TBL] [Abstract][Full Text] [Related]
17. Recent trends in the management of breast cancer. 1. Carcinoma in situ of the breast. Donegan WL Can J Surg; 1992 Aug; 35(4):361-5. PubMed ID: 1323379 [TBL] [Abstract][Full Text] [Related]
18. Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases. Cutuli B; De Lafontan B; Kirova Y; Auvray H; Tallet A; Avigdor S; Brunaud C; Delva C Radiat Oncol; 2015 May; 10():110. PubMed ID: 25944033 [TBL] [Abstract][Full Text] [Related]
19. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision. Renshaw AA; Derhagopian RP; Martinez P; Gould EW Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208 [TBL] [Abstract][Full Text] [Related]
20. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)? Lakhani SR; Audretsch W; Cleton-Jensen AM; Cutuli B; Ellis I; Eusebi V; Greco M; Houslton RS; Kuhl CK; Kurtz J; Palacios J; Peterse H; Rochard F; Rutgers E; Eur J Cancer; 2006 Sep; 42(14):2205-11. PubMed ID: 16876991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]